Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in...

Area of Science:

• Immunology
• Biochemistry

Background:

• The Complement system is crucial for innate immunity.
• Understanding Complement pathway activation dynamics is vital for clinical applications.

Purpose of the Study:

• To quantitatively analyze the kinetics of Complement system activation via lectin and alternative pathways in vitro.
• To determine the threshold for terminal pathway activation relative to upper Complement activation.
• To explore the clinical relevance of assessing Complement activation capacity.

Main Methods:

• In vitro zymosan-activation of pooled human serum over a 24-hour time-course.
• Quantitative measurement of Complement fragments C3a and C5a concentrations.
• Analysis of C3a:C5a molar ratios to assess pathway activation dynamics.

Main Results:

• Upper Complement activation reached a maximum of 39%, with time-to-maximum activation decreasing non-linearly with zymosan dose.
• A flux threshold for terminal pathway activation was identified, occurring when >31% of C3 molecules are activated.
• Upper Complement activation was found to be approximately 50-fold greater than terminal activation (opsonization vs. membrane attack complex formation).

Conclusions:

• The relative activity of opsonization significantly exceeds membrane attack complex formation in pooled human serum in vitro.
• Assessing a patient's upper Complement activation capacity could identify individuals at risk of infections or sepsis, particularly those with exhausted Complement function.
• Potential clinical applications include pre-operative or admission assessment of Complement status to guide patient management and predict complications.